- Member Center
- Professional Groups
|The 2017 IP100® Executive Forum|
Confirmed Speakers and Panel Topics Added!
The 2017 IP100® Executive Forum
The Future of I_ (Property, Assets, Capital?): Nothing is Certain but Change
|Continuing Education||Advisory Board||Attendee Eligibility||Invitation Request||Register|
The IP100® Value Proposition
The IP100 Executive Forum is a unique and exclusive gathering of experienced and knowledgeable licensing professionals and senior executives charged with the IP decision-making responsibilities within their organizations. The IP100 focuses on strategic issues related to IP business, including IP valuation and monetization, best practices in deal structure, IP strategy, and organizational alignment.
Held annually, the event explores the business dynamics of IP and organizational strategy through panels and small, facilitated group discussions, where the focus is on peer-to-peer interactions, thought-provoking engagement, and valuable takeaways to implement and integrate immediately into your organization. Attendance is limited to experienced, management-level professionals from IP-owning organizations of all sizes including industry, academia and Federal labs.
“From its inception, I’ve been involved in the IP100 because I learn so much. I learn about new trends in IP management, best practices across a variety of industries, what issues my peers are wrestling with, and how they are handling them. And I learn all this in a trusting and productive environment, where I’m not bothered by service providers or press. I can relax and engage in useful conversations with people like me – senior business people responsible for their companies’ IP functions – who are solving the same problems that I need to solve.”-Bill Elkington, Senior Director, Intellectual Property Management, Rockwell Collins
Attendees of previous IP100 Executive Forums include representatives from:
Advanced Research Projects Agency
Bob Mackie Design Group, Ltd.
Boehringer Pharmaceuticals, Inc.
Brookhaven National Laboratory
Dow Chemical Company
Eli Lilly and Company
GE Technology Ventures
Georgia Power Company
Johnson & Johnson
Merck & Co.
Pacific Gas & Electric Company
Procter & Gamble
Sandia National Laboratories
The Nielsen Company
United States Patent and Trademark Office